Dr. Ann Marie Egloff
Lead Investigator and Assistant Professor in Pittsburgh, PA
Dr. Ann Marie Egloff was born in Owosso, Michigan, in a family where education and community involvement were highly valued. Her parents, both educators—her mother teaching science and her father serving as a school administrator—instilled a strong sense of learning and giving back to the community. At Swartz Creek High School, she excelled academically, earning honors in math and science and engaging in extracurricular activities like varsity basketball, track and field, diving, and the arts, including theater and ballet.
Dr. Egloff's academic path took her to the University of Michigan, where she obtained her Bachelor of Science in Cellular and Molecular Biology. This laid the foundation for her entry into biomedical research, with her first professional experience at Warner-Lambert Parke-Davis. She was recognized for her work in molecular cloning and small-molecule inhibitors, which were used to explore therapeutic targets for cancer and metabolic diseases.
Her desire to deepen her research led her to pursue a PhD in Biochemistry, Cell, and Molecular Biology at Johns Hopkins School of Medicine. Her dissertation focused on immune cell signaling pathways, which significantly impact cellular responses to various diseases. After completing her PhD, she went on to a postdoctoral fellowship at the National Human Genome Research Institute, where she contributed to research on cancer-causing gene mutations, which earned her notable awards.
Dr. Egloff advanced her career at the University of Pittsburgh by joining an NIH/NCI-sponsored Cancer Education and Career Development Program. Her work in this program focused on applying laboratory findings to clinical settings, aiming to improve cancer treatments through personalized approaches. She later became an Assistant Professor at the University of Pittsburgh School of Medicine, where she led research into head and neck cancers, contributing to groundbreaking developments in genomics and cancer treatment.
In 2015, Dr. Egloff moved to Boston University, where she continued to expand her research and mentorship roles. She works at Brigham and Women’s Hospital and Harvard Medical School, where her research focuses on tumor immunology and precision medicine.
Dr. Ann Marie Egloff’s work extends beyond the laboratory. She is actively involved in her community in Somerville, Massachusetts, participating in local projects and supporting several non-profit organizations.
Website: https://annmarieegloff.com/